Endo Int'l (NASDAQ: ENDP) reported Q2 EPS of $0.93, $0.20 better than the analyst estimate of $0.73. Revenue for the quarter came in at $876 million versus the consensus estimate of $836.41 million.

GUIDANCE:

Endo Int'l sees FY2017 EPS of $3.35-$3.65, versus the consensus of $3.53. Endo Int'l sees FY2017 revenue of $3.38-3.53 billion, versus the consensus of $3.49 billion.

For earnings history and earnings-related data on Endo Int'l (ENDP) click here.